Aplastic anemia: Difference between revisions
imported>Howard C. Berkowitz No edit summary |
mNo edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 12: | Line 12: | ||
[[Fanconi's anemia]] is the most common hereditary aplastic anemia. Genes involved in [[DNA mismatch repair]] have been implicated in [[Fanconi's anemia]], and aplastic anemia usually takes place before adulthood. | [[Fanconi's anemia]] is the most common hereditary aplastic anemia. Genes involved in [[DNA mismatch repair]] have been implicated in [[Fanconi's anemia]], and aplastic anemia usually takes place before adulthood. | ||
==Drugs and aplastic anemia== | ==Drugs and aplastic anemia== | ||
Clinicians will avoid drugs associated with aplastic anemia unless there is no better | Clinicians will avoid drugs associated with aplastic anemia unless there is no better choice, which is indeed the case. Not all drugs carry the same risk, and thus are more likely to be used. In the list below, for example, there are usually alternatives to [[chloramphenicol]], but most anticonvulsants are on the list: | ||
*[[Phenylbutazone]] | *[[Phenylbutazone]] | ||
*[[Chloramphenicol]] | *[[Chloramphenicol]] | ||
| Line 28: | Line 28: | ||
*[[Allopurinol]] | *[[Allopurinol]] | ||
*[[Furosemide]] | *[[Furosemide]] | ||
==Radiation-induced aplastic anemia== | ==Radiation-induced aplastic anemia== | ||
[[Acute radiation syndrome]] with a single exposure to 5 Gy of radiation energy will kill 50 percent of recipients, due to irreversible injury to hematopoeitic stem cells. | [[Acute radiation syndrome]] with a single exposure to 5 Gy of radiation energy will kill 50 percent of recipients, due to irreversible injury to hematopoeitic stem cells. | ||
| Line 34: | Line 35: | ||
==Treatment== | ==Treatment== | ||
==References== | ==References== | ||
<references/> | <references/>[[Category:Suggestion Bot Tag]] | ||
Latest revision as of 16:00, 11 July 2024
Aplastic anemia is clinical syndrome, characterized by a hypoplastic bone marrow in the setting of pancytopenia. The pathogenesis of aplastic anemia is damage to the pluripotent stem cell reserves of the bone marrow, which leads to profound low white blood cell, red blood cell, and platelet counts.
Patterns of aplastic anemia include:
- Hereditary
- Drug-induced
- Radiation
- Infection
- Idiopathic
Hereditary forms of aplastic anemia
Fanconi's anemia is the most common hereditary aplastic anemia. Genes involved in DNA mismatch repair have been implicated in Fanconi's anemia, and aplastic anemia usually takes place before adulthood.
Drugs and aplastic anemia
Clinicians will avoid drugs associated with aplastic anemia unless there is no better choice, which is indeed the case. Not all drugs carry the same risk, and thus are more likely to be used. In the list below, for example, there are usually alternatives to chloramphenicol, but most anticonvulsants are on the list:
- Phenylbutazone
- Chloramphenicol
- Gold
- Sulfonamides
- Sulfonylureas, such as glipizide
- Felbamate
- Carbamazepine
- Valproic acid
- Phenytoin
- Nifedipine
- Ticlopidine [1]
- Clopidogrel [2]
- Penicillin
- Allopurinol
- Furosemide
Radiation-induced aplastic anemia
Acute radiation syndrome with a single exposure to 5 Gy of radiation energy will kill 50 percent of recipients, due to irreversible injury to hematopoeitic stem cells.
Infection-induced aplastic anemia
Idiopathic aplastic anemia
Treatment
References
- ↑ Symeonidis A, Kouraklis-Symeonidis A, Seimeni U, Galani A, Giannakoulas N, Fragopanagou E, Tiniakou M, Matsouka P, Zoumbos N (2002). "Ticlopidine-induced aplastic anemia: two new case reports, review, and meta-analysis of 55 additional cases". Am J Hematol 71 (1): 24-32. PMID 12221670.
- ↑ Meyer B, Staudinger T, Lechner K (2001). "Clopidogrel and aplastic anaemia". Lancet 357 (9266): 1446-7. PMID 11360950.